Literature DB >> 2907060

Vascular reactivities of isolated and perfused human ciliary arteries.

H Ohkubo1, S Chiba.   

Abstract

The vascular responses to 8 agents, norepinephrine (NE), phenylephrine (PHE), xylazine (XYL), tyramine (TYR), dopamine (DA), 5-hydroxytryptamine (5-HT), prostaglandin F2 alpha (PGF2 alpha) and KCl were examined in human posterior ciliary arteries (HPCAs) which were isolated and perfused with Tyrode's solution gassed with 95% O2 and 5% CO2 under a constant flow rate at 37 degrees C. The rank order for potency of vasoconstrictions was 5-HT greater than NE greater than PHE = PGF2 much greater than DA greater than TYR much greater than KCl. Responses to XYL were various but not significant. DA frequently induced a vasodilatation at smaller doses but a vasoconstriction at larger doses. Although their antagonists were not used in this study, it was suggested that 1) there are rich alpha-1 adrenoceptors and 5-HT receptors, 2) dopaminergic receptors exist in these arteries and 3) there are rich tyramine-sensitive catecholamine stores in nerve terminals.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2907060

Source DB:  PubMed          Journal:  Jpn J Ophthalmol        ISSN: 0021-5155            Impact factor:   2.447


  4 in total

Review 1.  Use of isolated ocular arteries in vitro to define the pathology of vascular changes in glaucoma.

Authors:  C H Buckley; P W Hadoke; C J O'Brien
Journal:  Br J Ophthalmol       Date:  1997-07       Impact factor: 4.638

2.  Common histopathological changes in aged human orbital arteries.

Authors:  E R Büchi; P Schiller; M Felice; A Bunkenburg; B Daicker
Journal:  Int Ophthalmol       Date:  1993-02       Impact factor: 2.031

3.  Serotonin (5-HT) and the rat's eye. Some pilot studies.

Authors:  R M Boerrigter; J V Siertsema; I P Kema
Journal:  Doc Ophthalmol       Date:  1992       Impact factor: 2.379

4.  Role of the endothelium in modulating functional responses of isolated bovine anterior ciliary arteries to vasoconstrictor agonists.

Authors:  C H Buckley; P W Hadoke; C J O'Brien
Journal:  Br J Ophthalmol       Date:  1998-07       Impact factor: 4.638

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.